Mounjaro

Description

Mounjaro is an injectable medicine containing the active substance tirzepatide, used once weekly to treat adults with type 2 diabetes alongside diet and exercise. It works by activating two hormone receptors, GLP-1 and GIP, to help regulate blood sugar by increasing insulin release when blood sugar is high, reducing glucose production by the liver, and slowing digestion. This multi-action approach helps lower blood sugar levels and HbA1c effectively.
Mounjaro can be used as monotherapy when metformin is unsuitable or alongside other diabetes medicines. It also supports weight loss, primarily through fat mass reduction, and improves other health markers such as blood pressure and blood fat levels. The medication is administered through a prefilled pen injected under the skin in the abdomen, thigh, or upper arm once weekly, and it requires a prescription.
Clinical studies show that Mounjaro is effective in controlling blood glucose without significantly increasing the risk of low blood sugar episodes. Its safety profile is carefully monitored, with side effects considered manageable